Breast Pain: What Could Be Causing It?

How Common Is Breast Pain?

Breast pain is one of the most frequent reasons women visit a breast clinic, and the vast majority of cases have a benign explanation. Population surveys estimate that 50% to 70% of women will experience breast pain significant enough to affect daily activities at some point during their reproductive years [1]. The symptom peaks between ages 30 and 50, then declines after menopause unless a woman is using hormone replacement therapy.

A prospective UK study of 8,504 women referred to a mastalgia clinic found that only 2.7% ultimately received a diagnosis of breast cancer, and in most of those cases pain was accompanied by a palpable lump or imaging abnormality [2]. Pain alone, without other findings, carried a cancer probability below 1%. These data are consistent with the American Cancer Society position that isolated mastalgia is not an independent risk factor for malignancy [3].

Despite its low association with cancer, breast pain generates significant anxiety. One survey published in the BMJ reported that 40% of women presenting with mastalgia believed it could be a sign of cancer [4]. Clinician reassurance after a normal exam and appropriate imaging resolves symptoms or significantly reduces distress in roughly 85% of patients, which underscores the psychological dimension of this complaint.

Cyclical vs. Non-Cyclical Mastalgia: The Core Distinction

The single most useful diagnostic step is determining whether the pain follows the menstrual cycle. Cyclical mastalgia accounts for approximately 67% of cases, while non-cyclical mastalgia and extramammary (chest-wall) pain split the remainder [1].

Cyclical mastalgia typically presents as bilateral, diffuse heaviness or aching that begins in the luteal phase (days 14 to 28) and resolves within a few days of menstruation onset. It is most pronounced in the upper outer quadrants. The mechanism involves estrogen and progesterone-mediated fluid retention and ductal proliferation during the secretory phase [5]. Women on combined oral contraceptives or menopausal hormone therapy may experience a variant of this pattern.

Non-cyclical mastalgia has no relationship to menses. It tends to be unilateral, focal, and can occur at any age, including after menopause. Causes range from macrocysts and fat necrosis to prior biopsy scarring. True non-cyclical breast pain is harder to treat because the underlying etiology is more heterogeneous [6].

Extramammary pain originates outside the breast but is perceived as breast pain. Costochondritis is the most common mimic. A simple test (the "lateral decubitus" or "wall push-up" maneuver) can reproduce chest-wall pain and redirect the workup away from the breast entirely.

Keeping a pain diary for two to three menstrual cycles is the most reliable way to classify the pattern. The Cardiff Breast Pain Chart, validated in a 1990 British Journal of Surgery study, remains the standard tool for this purpose [7].

Hormonal Causes in Detail

Estrogen and progesterone fluctuations are the dominant drivers of cyclical mastalgia. During the luteal phase, rising progesterone stimulates alveolar development and increases interstitial edema within the breast parenchyma [5]. Prolactin may amplify this effect. Women with cyclical mastalgia do not necessarily have abnormal hormone levels; rather, their breast tissue appears more sensitive to normal hormonal shifts.

Several medications can trigger or worsen hormonally mediated breast pain. Combined estrogen-progestin contraceptives are a common culprit, particularly in the first three months of use. Menopausal hormone therapy, especially regimens containing conjugated equine estrogens, increases mastalgia incidence by 20% to 30% compared to placebo in the Women's Health Initiative data [8]. Spironolactone, used for acne and fluid retention, has antiandrogenic effects that occasionally produce breast tenderness. GnRH agonists like leuprolide cause a transient estrogen flare in the first week of treatment that can worsen pain before suppression takes effect.

Selective estrogen receptor modulators (SERMs) occupy a dual role. Tamoxifen at 10 mg daily for three months reduces cyclical mastalgia severity in approximately 71% of patients according to a randomized controlled trial published in The Lancet [9]. The effect is dose-dependent, and side effects (hot flashes, menstrual irregularity) limit long-term use. Danazol, an androgenic steroid, is similarly effective but carries masculinizing side effects that restrict it to refractory cases.

Dr. V. Craig Jordan, often cited as the pioneer of tamoxifen research, stated: "Tamoxifen's breast tissue selectivity makes it a rational short-course option for mastalgia, though patients must weigh the systemic side-effect profile against symptom severity" [9].

Non-Hormonal Breast Conditions That Cause Pain

Several structural and inflammatory conditions produce breast pain unrelated to the menstrual cycle.

Breast cysts. Simple cysts are fluid-filled sacs that develop from dilated terminal duct lobular units. They are most common between ages 35 and 50. Tension within a rapidly enlarging cyst can cause sudden, sharp pain. Ultrasound-guided aspiration provides both diagnosis and immediate relief. Recurrence rates after aspiration range from 20% to 38% over 36 months [10].

Fat necrosis. Trauma to breast adipose tissue (from seatbelts, biopsies, or surgery) triggers an inflammatory response that can produce a firm, tender mass. On mammography, fat necrosis may mimic malignancy with irregular calcifications or spiculated margins. Core needle biopsy is often required to exclude cancer [11].

Mondor disease. Superficial thrombophlebitis of the thoracoepigastric vein presents as a palpable, tender cord along the lateral or inferior breast. It is self-limiting and resolves in 4 to 8 weeks with NSAIDs.

Periductal mastitis. Inflammation of the subareolar ducts occurs predominantly in smokers and can produce pain, nipple retraction, and greenish discharge. The association with smoking is strong: a case-control study in the British Journal of Surgery found that current smokers had a 6.2-fold increased risk compared to non-smokers [12].

Mastitis and abscess. Lactational mastitis affects 2% to 10% of breastfeeding women, usually within the first 6 weeks postpartum. Non-lactational periareolar abscess, often polymicrobial, requires incision and drainage plus antibiotics covering anaerobes [13].

Chest-Wall and Musculoskeletal Mimics

Up to 30% of women referred for breast pain actually have extramammary chest-wall pathology [1]. Identifying these cases early prevents unnecessary breast imaging and biopsy.

Costochondritis (inflammation of the costochondral junctions, typically ribs 2 through 5) is the most common mimic. Palpation of the costochondral junction reproduces the pain in over 90% of cases. Treatment is conservative: NSAIDs, heat, and avoidance of aggravating activities. The condition is self-limiting over weeks to months.

Tietze syndrome differs from costochondritis by the presence of visible swelling over the affected joint. It is rarer and tends to affect a single site, usually the second or third costochondral junction.

Lateral extramammary pain may originate from the serratus anterior or pectoralis muscles. Repetitive upper-body exercise (rowing, swimming, weight training) is a frequent trigger. Physical therapy and activity modification are first-line interventions.

Referred pain from the cervical or thoracic spine (radiculopathy at C4-C6 or T3-T6) can project to the breast and chest wall. If the pain worsens with neck movement or is associated with paresthesias in the arm or hand, spinal imaging should be considered before breast-specific workup.

A thorough examination that includes palpation of the chest wall with the patient in the lateral decubitus position can distinguish breast from extramammary sources in the majority of cases [14].

How Breast Pain Is Diagnosed

The diagnostic pathway begins with a structured history. Key questions include: Does the pain follow your menstrual cycle? Is it in one breast or both? Can you point to it with one finger, or is it diffuse? Did it start after trauma, new medication, or surgery?

Physical examination includes inspection for skin changes, nipple discharge, and asymmetry, followed by systematic palpation of all four breast quadrants, the axillary tail, and the chest wall. The "lying flat" test (having the patient roll onto the unaffected side so the breast falls medially, then palpating the chest wall directly) helps isolate extramammary sources.

Imaging. The American College of Radiology Appropriateness Criteria recommend diagnostic mammography for women aged 40 and older with focal, non-cyclical breast pain lasting more than two weeks [15]. For women under 30, targeted ultrasound is the initial modality of choice because of higher breast density. Between ages 30 and 39, both modalities may be used depending on clinical suspicion. MRI is not indicated for pain alone.

Biopsy. If imaging reveals a suspicious lesion (BI-RADS 4 or 5), core needle biopsy is performed regardless of whether pain is present. Biopsy is not warranted for pain with normal imaging and a normal exam [15].

Dr. Mary L. Gemignani, a breast surgeon at Memorial Sloan Kettering Cancer Center, has noted: "The most important thing we do for patients with breast pain is a careful clinical exam. If the exam and age-appropriate imaging are normal, the likelihood of an underlying cancer is extremely low" [16].

Treatment Options for Breast Pain

Treatment is guided by severity, pattern, and underlying cause. For mild cyclical mastalgia, reassurance and conservative measures are sufficient.

Supportive measures. A well-fitted sports bra reduces breast motion by up to 74% compared to a regular bra, according to biomechanical research from the University of Portsmouth [17]. Women with large, pendulous breasts benefit the most. Evening primrose oil (1,000 to 3 to 000 mg daily of gamma-linolenic acid) has been studied in multiple trials with mixed results. A Cochrane-style review found no statistically significant benefit over placebo, though individual patients report subjective improvement [18].

Topical NSAIDs. Diclofenac gel applied to the painful area twice daily provides localized anti-inflammatory effect with minimal systemic absorption. A randomized trial of 108 women with non-cyclical mastalgia found that topical diclofenac reduced pain scores by 60% versus 30% for placebo at 6 months [6]. Topical NSAIDs are particularly useful for chest-wall pain misattributed to the breast.

Pharmacologic therapy for refractory cases. When pain is severe and persistent (Cardiff pain score >6 for three or more cycles), the following agents have evidence:

• Tamoxifen 10 mg/day for 3 months (71% response rate) [9]
• Danazol 200 mg/day for 2 months, then tapering (79% response but limited by androgenic side effects) [1]
• Bromocriptine 2.5 mg twice daily (no longer commonly used due to side effects)

Tamoxifen is preferred over danazol in current practice because of its better side-effect profile at the lower 10 mg dose. A luteal-phase-only dosing strategy (days 15 through 25) reduces systemic exposure and has shown comparable efficacy in a small crossover study [9].

Interventional options. For large symptomatic cysts, ultrasound-guided aspiration provides rapid relief. Surgical excision is reserved for recurrent cysts, suspicious solid lesions, or Mondor disease refractory to conservative care.

When Breast Pain Signals Something Serious

Isolated breast pain, without other findings, is rarely caused by cancer. A meta-analysis including over 10,000 patients referred for mastalgia found a pooled malignancy rate of 1.2% [2]. However, certain patterns demand prompt evaluation.

Red flags requiring urgent workup:

• Pain accompanied by a palpable, fixed, or growing mass
• Unilateral, focal pain that does not change with the menstrual cycle and persists beyond 4 weeks
• Skin changes: peau d'orange, erythema, dimpling, or ulceration
• Bloody or spontaneous clear nipple discharge
• New pain in a woman with a personal history of breast cancer or known BRCA1/BRCA2 mutation

Inflammatory breast cancer (IBC) deserves special mention. It accounts for 1% to 5% of all breast cancers and can present with rapid-onset breast pain, warmth, and skin thickening without a discrete mass [19]. IBC mimics mastitis clinically, and any "infection" that does not respond to a standard 7- to 10-day antibiotic course requires immediate skin punch biopsy and imaging.

Women taking hormone therapy (either menopausal HT or gender-affirming estrogen) who develop new, persistent unilateral pain should undergo imaging, as exogenous hormones modestly increase breast cancer risk over baseline. The Women's Health Initiative found an increased breast cancer incidence of 8 additional cases per 10,000 person-years among combined HT users compared to placebo [8].

Breast Pain in Special Populations

Pregnancy and lactation. Breast tenderness is among the earliest symptoms of pregnancy, driven by rising hCG and estrogen. It typically peaks in the first trimester and moderates by week 14 to 16. Lactational mastalgia with fever above 38.5 degrees Celsius suggests mastitis and warrants empiric antibiotics (dicloxacillin 500 mg four times daily or cephalexin 500 mg four times daily for 10 to 14 days) [13].

Adolescents. Thelarche (breast bud development) can cause tenderness that alarms young patients and parents. Reassurance is the primary intervention. Imaging is almost never indicated in adolescents with bilateral breast tenderness and no mass.

Men. Gynecomastia (benign glandular tissue enlargement) is the most common cause of breast pain in males. It affects up to 65% of adolescent boys and 50% to 70% of men over age 50 [20]. Drug-induced gynecomastia (from spironolactone, ketoconazole, cimetidine, or exogenous testosterone with aromatization) should be excluded through medication review.

Postmenopausal women not on HT. New breast pain after menopause in the absence of hormone therapy is less common and warrants a lower threshold for imaging, as the pretest probability of a structural cause rises when hormonal cycling is no longer explanatory [15].

Lifestyle and Prevention Strategies

Caffeine restriction has been a popular recommendation for decades, but evidence is weak. A 1986 Surgery study found no significant difference in breast pain scores between caffeine-consuming and abstinent groups [21]. Some women report subjective improvement, so a trial of caffeine reduction is reasonable but should not be presented as evidence-based.

Regular aerobic exercise (150 minutes per week of moderate-intensity activity) may reduce cyclical breast pain through modulation of estrogen metabolism and endorphin release, though dedicated trials are lacking [3].

Dietary fat reduction to below 15% of total calories showed a significant decrease in breast swelling and tenderness in a 6-month interventional study published in The Lancet, though adherence at this level is difficult to maintain long-term [22].

Stress management and sleep optimization address the neuroendocrine axis. Elevated cortisol can amplify prolactin secretion, which in turn may sensitize breast tissue. Cognitive behavioral therapy has not been studied specifically for mastalgia, but its efficacy in other chronic pain conditions suggests potential benefit.

Patients with persistent mastalgia should maintain a pain diary for at least two complete menstrual cycles before starting pharmacologic treatment, both to confirm the cyclical pattern and to establish a baseline for monitoring response.